Dn B Asset Management As Merck & Co., Inc. Transaction History

Dn B Asset Management As

$19.9 Billion
Q2 2024

A detailed history of Dn B Asset Management As transactions in Merck & Co., Inc. stock. As of the latest transaction made, Dn B Asset Management As holds 681,555 shares of MRK stock, worth $74.8 Million. This represents 0.42% of its overall portfolio holdings.

Number of Shares

681,555

Previous 646,425 5.43%

Holding current value

$74.8 Million

Previous $85.3 Million 1.08%

% of portfolio

0.42%

Previous 0.47%

28 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2024 Jul 05, 2024	BUY	$123.8 - $132.96 $4.35 Million - $4.67 Million	35,130 Added 5.43%	681,555 $84.4 Million
Q1 2024 Apr 12, 2024	SELL	$113.24 - $131.95 $9.44 Million - $11 Million	-83,339 Reduced 11.42%	646,425 $85.3 Million
Q4 2023 Jan 04, 2024	BUY	$100.18 - $109.02 $944,897 - $1.03 Million	9,432 Added 1.31%	729,764 $79.6 Million
Q3 2023 Oct 13, 2023	BUY	$102.95 - $114.33 $3.72 Million - $4.13 Million	36,108 Added 5.28%	720,332 $74.2 Million
Q2 2023 Jul 06, 2023	BUY	$108.61 - $118.38 $8.56 Million - $9.33 Million	78,804 Added 13.02%	684,224 $79 Million
Q1 2023 Apr 20, 2023	SELL	$102.94 - $114.86 $6.07 Million - $6.77 Million	-58,977 Reduced 8.88%	605,420 $64.4 Million
Q4 2022 Jan 12, 2023	BUY	$87.44 - $112.11 $902,555 - $1.16 Million	10,322 Added 1.58%	664,397 $73.7 Billion
Q3 2022 Oct 11, 2022	SELL	$84.53 - $94.96 $270,749 - $304,156	-3,203 Reduced 0.49%	654,075 $56.3 Million
Q2 2022 Jul 08, 2022	SELL	$83.49 - $94.64 $1.73 Million - $1.96 Million	-20,716 Reduced 3.06%	657,278 $59.9 Billion
Q1 2022 Apr 08, 2022	BUY	$73.51 - $82.4 $1.87 Million - $2.09 Million	25,402 Added 3.89%	677,994 $55.6 Million
Q4 2021 Jan 12, 2022	BUY	$72.28 - $90.54 $11,564 - $14,486	160 Added 0.02%	652,592 $50 Million
Q3 2021 Oct 15, 2021	BUY	$71.68 - $78.83 $1.89 Million - $2.08 Million	26,359 Added 4.21%	652,432 $49 Million
Q2 2021 Jul 06, 2021	BUY	$70.31 - $77.77 $6.02 Million - $6.66 Million	85,616 Added 15.84%	626,073 $48.7 Billion
Q1 2021 Apr 15, 2021	BUY	$68.86 - $81.11 $2.83 Million - $3.34 Million	41,122 Added 8.24%	540,457 $39.8 Million
Q4 2020 Jan 19, 2021	SELL	$71.77 - $79.65 $3.78 Million - $4.2 Million	-52,713 Reduced 9.55%	499,335 $39 Million
Q3 2020 Oct 14, 2020	BUY	$73.18 - $82.95 $856,864 - $971,261	11,709 Added 2.17%	552,048 $43.7 Million
Q2 2020 Jul 08, 2020	BUY	$70.42 - $80.13 $5.66 Million - $6.44 Million	80,396 Added 17.48%	540,339 $41.8 Billion
Q1 2020 Apr 17, 2020	SELL	$63.36 - $87.82 $4.26 Million - $5.91 Million	-67,281 Reduced 12.76%	459,943 $33.8 Million
Q4 2019 Jan 13, 2020	SELL	$77.58 - $87.54 $4.22 Million - $4.76 Million	-54,422 Reduced 9.36%	527,224 $45.8 Million
Q3 2019 Oct 16, 2019	SELL	$76.08 - $82.93 $6.24 Million - $6.8 Million	-81,972 Reduced 12.35%	581,646 $46.7 Million
Q2 2019 Jul 08, 2019	BUY	$69.84 - $81.59 $2.35 Million - $2.75 Million	33,700 Added 5.35%	663,618 $0
Q1 2019 Apr 11, 2019	BUY	$69.58 - $79.36 $816,312 - $931,051	11,732 Added 1.9%	629,918 $0
Q4 2018 Jan 15, 2019	BUY	$65.24 - $75.71 $3.58 Million - $4.16 Million	54,921 Added 9.75%	618,186 $45.1 Million
Q3 2018 Oct 10, 2018	BUY	$57.69 - $67.84 $3.51 Million - $4.13 Million	60,886 Added 12.12%	563,265 $0
Q2 2018 Jul 06, 2018	BUY	$50.83 - $59.72 $360,893 - $424,012	7,100 Added 1.43%	502,379 $0
Q1 2018 Apr 11, 2018	SELL	$50.96 - $59.23 $2.25 Million - $2.62 Million	-44,200 Reduced 8.19%	495,279 $0
Q4 2017 Jan 10, 2018	BUY	$51.62 - $61.64 $13.3 Million - $15.9 Million	257,640 Added 91.41%	539,479 $0
Q3 2017 Oct 11, 2017	BUY	$58.67 - $63.13 $16.5 Million - $17.8 Million	281,839	281,839 $0

Others Institutions Holding MRK

# of Institutions

3,826

Shares Held

1.91B

Call Options Held

13.4M

Put Options Held

10.7M

View Full List

About Merck & Co., Inc.

Ticker MRK
Exchange NYSE
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 2,533,280,000
Market Cap $278B
Description
Merck & Co., Inc. operates as a healthcare company worldwide. It operates through two segments, Pharmaceutical and Animal Health. The Pharmaceutical segment offers human health pharmaceutical products in the areas of oncology, hospital acute care, immunology, neuroscience, virology, cardiovascular, and diabetes, as well as vaccine products, ...

More about MRK

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Dn B Asset Management As, based on Form 13F filings with the SEC.

News

Stay updated on Dn B Asset Management As with notifications on news.

Account

Dn B Asset Management As Merck & Co., Inc. Transaction History